Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

J Travel Med. 2021 Jun 1;28(4):taab051. doi: 10.1093/jtm/taab051.

Affiliations

¹ Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India.
² Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana 500078, India.
³ Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box 4911, Ansari Nagar, New Delhi 110029, India.

No abstract available

Keywords: N501Y; SARS-CoV-2; escape mutants, vaccine efficacy; neutralization; variant of concern.

MeSH terms

Antibodies, Neutralizing
Antibodies, Viral
COVID-19 / prevention & control*
COVID-19 / virology
COVID-19 Vaccines / immunology*
Humans
SARS-CoV-2*
Vaccines, Inactivated / immunology

Substances

Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines
Vaccines, Inactivated